| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.3 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.033 | 0.3 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.056 | 0.3 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |